Crescent Biopharma, Inc.
Support and Resistance Levels
Past performance
News About CBIO
All events for CBIO
All deals for CBIO
Financial Ratios
Financial Statements
CBIO vs Sector & Peers
About Crescent Biopharma, Inc.
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts. Website crescentbiopharma.com
Headquarters Waltham, MA, US